https://www.selleckchem.com/pr....oducts/Cyclopamine.h
For PET2.SUVmax's performances, Se, Sp, PPV and NPV were respectively 67% (CI95% 48-81%), 77% (CI95% 64-97%), 67% (CI95% 48-82%), 77% (CI95% 64-87%). ROC curves for these predictors were similar; the areas under the curve were 0.6 (CI95% 0.56-0.64) for PET2.SUVmax and 0.55 (CI95% 0.50-0.59) for CGFL/Curie nomogram. Combined prediction was efficient with Se at 80%, VPN at 76%, Sp at 78% and VPP at 81 %. Conclusions CGFL/Curie nomogram and PET2.SUVmax were two efficient predictors of pCR in patients with HER2-positive breast cancer. C
Me gusta
Comentario
Compartir